nivi-development-petroleum

About

NIVI-Development will facilitate the translational efforts of NIVI-Research by providing industry-level expertise in vaccine development and conducting the early clinical testing of our vaccine candidates. 

MISSION & VISION

Facilitating translational efforts of NIVI

Bridging research, translational sciences, and development

NIVI Development will catalyse progress towards achieving the NIVI mission by enabling access to cutting-edge technologies and data-driven approaches to design, test, and optimise novel vaccine candidates. NIVI Development provides capabilities and expertise – either directly, or via external strategic partnerships – to bridge exploratory research and clinical (Phase 1 & 2, including CHIM) translational development.

NIVI Development will focus on the clinical and manufacturing process for new candidate vaccines. These projects will either come from our colleagues in NIVI Research or be in-licensed directly.

Particular skillsets at NIVI Development include, CMC development, Clinical, Regualtory and Business Development.

 

objectives

Developing vaccines for a better future

NIVI will focus on airborne pathogens and will examine the mucosal immune system in detail. Ultimately, we intend to develop vaccines which can be delivered into the airway which is, of course, where infection actually occurs. Such a scientific development could be considered “game changing” since not only would this prevent serious disease, but it could also play a role in prevention of infection in the first place.

ENABLE

NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships.

NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships. NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships.

Expand

OPTIMIZE

Optimize early process development and technology transfer. NIVI Development will ensure that quality considerations are implemented and documented from early discovery.

Optimize early process development and technology transfer. NIVI Development will ensure that quality considerations are implemented and documented from early discovery. Optimize early process development and technology transfer. NIVI Development will ensure that quality considerations are implemented and documented from early discovery. 

Optimize early process development and technology transfer. NIVI Development will ensure that quality considerations are implemented and documented from early discovery.

Expand

OVERSEE

If NIVI’s research results in a lead vaccine candidate with promising data, a professional vaccine development team will develop a detailed proposal and budget for advanced vaccine development and clinical testing.

NIVI Development will then coordinate the production of GMP-certified vaccines and oversee Phase 1 and 2 clinical trials in collaboration with dedicated clinical trial partners. Once NIVI has a promising lead vaccine candidate with supporting clinical trial data, the vaccine package including intellectual property (IP) rights, preclinical/clinical data, and manufacturing know-how will be out-licensed to a commercial partner for further clinical development, large-scale manufacturing, and marketing under relevant global access and revenue sharing agreements. Any revenue will be reinvested in NIVI.

Expand

Constantly progressing

Join the team

Constantly expanding

Join the team